Sign in with Google. Opens in new tab
ENTITY
HK inno.N

HK inno.N (195940 KS)

40
Analysis
Health CareSouth Korea
HK inno.N Corp. develops and manufactures pharmaceuticals products. The Company develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products. HK inno.N conducts businesses across worldwide.
more
bullishHK inno.N
05 Jul 2021 10:45

HK Inno.N IPO Valuation Analysis

Our base case valuation  of HK Inno.N is 75,534 won per share, which represents a 28% upside from the high end of the IPO price range. We have a...

Logo
303 Views
Share
bullishHK inno.N
01 Jul 2021 16:51

HK Inno.N IPO Preview

HK Inno.N is getting ready for an IPO in the Korean stock market. The IPO price range is from 50,000 won to 59,000 won. The IPO deal size is from...

Logo
460 Views
Share
x